MIR SCIENTIFIC
History
| Year | Detail |
|---|---|
| 2013 | Founded in 2013 and headquartered in New York, miR Scientific is a precision healthcare company that aims to improve public health by transforming cancer management globally. |
| 2022 | The company commercially launched the miR Sentinel Prostate Cancer Test in the U.S., Puerto Rico, and select international markets. It is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm. |
